An international scientific group including a RUDN chemist have developed a complex copper-based compound with stronger antibacterial properties compared to analogs, and is cheaper to produce. The scientists confirmed that its effect is determined not by the substance's decomposition in the body, but by targeted influence on bacteria. The study was published in the Journal of Molecular Structure.